Skip to main
KALV
KALV logo

KalVista Pharma (KALV)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy KalVista Pharma (KALV) Stock

About KalVista Pharma (KALV)

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crocket...read more
Market cap$644.31M
Today's volume772.13K
Revenue (TTM)
Avg. daily volume594.64K
EBITDA (TTM)-$180.52M
Open$13
Price / earnings ratio-3.48x
Today's range$12.84 - $13.37
Debt / equity73.52x
52 week range$7.3 - $15.5
5 year debt / equity3.3x
Beta (LTM)0.97x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio10.44x
Ex-dividend date
Next earningsJul 10, 2025
Dividend payable date

KalVista Pharma Stock Rating

What analysts recommend for KALV stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 69%
Buy 31%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for KALV stock is $644.32M

The current P/E ratio for KALV stock is -3.48

The 52-week high for KALV stock is $15.50. The current KALV stock price $undefined is 100.00% below its 52-week high

The 52-week low for KALV stock is $7.30. The current KALV stock price $undefined has increased 100.00% from its 52-week low

No, the KALV stock does not pay dividends to its shareholders

The target price for KALV stock is $27.08 based on the average of what a group of analyst think KALV stock could be worth at a future date. This is not a prediction by Public.com

How to buy KALV stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in KALV stock

    Navigate to the Explore page. Then, type KALV into the search bar. When you see KALV stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased KALV stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

KalVista Pharma Stock Earnings

The value each KALV share was expected to gain vs. the value that each KALV share actually gained.

KalVista Pharma (KALV) reported Q3 2025 earnings per share (EPS) of -$0.92, missing estimates of -$0.88 by 4.55%. In the same quarter last year, KalVista Pharma's earnings per share (EPS) was -$0.84. KalVista Pharma is expected to release next earnings on 07/10/2025, with an earnings per share (EPS) estimate of -$0.92.

Buy KalVista Pharma (KALV) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.